&w=3840&q=100)
2 smallcaps zoom up to 153% from April low. What's driving these stocks?
Share price of Suven Life Sciences, Camlin Fine Sciences today
Shares of Suven Life Sciences (Suven) and Camlin Fine Sciences (CFSL) hit their respective new highs, surging up to 9 per cent on the BSE in Monday's intra-day trade. The stock price of both these smallcap companies have outperformed the market, by zooming up to 153 per cent from their April month lows. On April 7, 2025, the market including BSE Sensex, BSE Midcap and BSE Smallcap indices recorded their respective 52-week lows.
Individually, Suven has rallied 9 per cent to ₹257.70 in intra-day trade today. In the past one month, the market price of the healthcare research, analytics & technology company has surged 36 per cent. It has bounced back 124 per cent from its April 7, 2025 low of ₹115 on the BSE.
Shares of Camlin soared 7 per cent to ₹324.20, surging 67 per cent in the past one month. The stock price of this specialty chemicals makee has zoomed 153 per cent from a level of ₹128.10 touched on April 7, 2025.
What's driving Suven, Camlin stock prices?
CFLS reported a strong operational performance for the March 2025 quarter (Q4FY25). The company reported 88.7 per cent year-on-year (YoY) growth in earnings before interest, taxes, depreciation and amortisation (EBITDA) from its continuing operations at ₹59.41 crore, as against ₹31.48 crore in Q4FY24. Reported EBITDA margins expanded to 13.6 per cent from 8.4 per cent from the year ago quarter. Revenue from operations grew 16.1 per cent YoY to ₹437.46 crore from ₹376.65 crore. Profit after tax (PAT) increased 16.9 per cent YoY at ₹22.74 crore.
At the consolidated level, CFSL derives around 85 per cent of its revenue from exports and from overseas subsidiaries, with over 100 products sold in around 80 countries. The company caters to diverse end user industries such as food, feed, animal and pet nutrition, flavours and fragrances, pharma, agrochemicals, and petrochemicals among others. This helps the company avoid dependence on any single industry and provides potential for expansion.
Management anticipates sustained momentum in this segment, projecting a compounded annual growth rate (CAGR) of ~20 per cent over the next 2–3 years. Margins are expected to expand further as the bleeding from continued operations reduces and other operations grow. Camlin is also set to benefit from the implementation of anti-dumping measures in the US and improving Vanillin prices. While steady performance improvement is expected, the analysts remain cautious of near-term uncertainties related to tariffs and capacity ramp-up.
Suven, a bio-pharmaceutical company, engaged in Drug Discovery and Development of New Chemical Entities (NCEs) in Central Nervous System (CNS) disorders targeting unmet medical needs, globally.
On May 13, the board of directors of Suven approved fund raising of ₹857.64 crore through fully convertible warrants on preferential basis to continue the funding of R&D, Clinical Development programs and general corporate purposes and CAPEX for creating new R&D facilities.
Suven has a significant opportunity in the rapidly growing CNS segment. The segment has limited competition due to high associated risks. CNS diseases include a broad spectrum of disorders in which the brain or spinal cord functioning is diminished or impaired, resulting in diminished motor, sensory, or cognitive performance.
The rising prevalence of CNS disorders, such as Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis and depression, drives the demand for effective CNS therapeutics. Furthermore, the pandemic has resulted in increased stress levels, anxiety, depression and other mental conditions. This has led to an increased demand for CNS therapies.
Suven continues its R&D programs focused on CNS disease disorders and has secured 20 patents during the period covering countries Brazil, Eurasia, Europe, Hong Kong, India, Israel, Japan, Macao, Mexico, New Zealand, Sri Lanka, South Africa and the US.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
34 minutes ago
- Economic Times
Stock market update: Nifty Bank index falls 0.54% in a weak market
NEW DELHI: The Nifty Bank index traded negative around 10:58AM(IST)on Monday in a weak market. ADVERTISEMENT IDFC First Bank Ltd.(up 0.93 per cent), Au Small Finance Bank Ltd.(up 0.71 per cent) and Punjab National Bank(up 0.17 per cent) were among the top gainers. Axis Bank Ltd.(down 0.85 per cent), ICICI Bank Ltd.(down 0.76 per cent), HDFC Bank Ltd.(down 0.73 per cent), IndusInd Bank Ltd.(down 0.7 per cent) and State Bank of India(down 0.7 per cent) were the top losers on the index. The Nifty Bank index was down 0.54 per cent at 55949.05 at the time of writing this report. Benchmark NSE Nifty50 index was down 196.81 points at 24915.6, while the BSE Sensex was down 668.33 points at 81739.84. Among the 50 stocks in the Nifty index, 9 were trading in the green, while 41 were in the red. ADVERTISEMENT Shares of Vodafone Idea, Ola Electric Mobilit, RattanIndia Power, Zee Ent. and YES Bank were among the most traded shares on the NSE. Shares of Madhya Bharat Agro, SRM Contractors, Apollo Micro Systems, Quality Power Electr and Reliance Naval & Engg hit their fresh 52-week highs in today's trade, while Osia Hyper Retail, Omkar Speciality, Lasa Supergenerics, Navkar Builders and Sadhana Nitro hit fresh 52-week lows in trade. (You can now subscribe to our ETMarkets WhatsApp channel)


Mint
35 minutes ago
- Mint
Indian benchmarks drop 1% as investors fret over heightened Mideast tensions
(Reuters) -India's equity benchmarks fell 1% on Monday after U.S. attacks on Iranian nuclear sites fuelled fears of a further escalation in Middle East tensions and pushed oil prices to a five-month high. The Nifty 50 and the BSE Sensex were down 0.9% each at 24,890.03 points and 81,659.09 points, respectively, as of 10:37 a.m. IST. All 13 major sectors traded lower. The broader mid-caps fell 0.2% and small-caps were flat. The U.S. bombed Iranian nuclear sites over the weekend, joining Israel in the biggest Western military action against the Islamic Republic since the 1979 revolution. Most Asian stocks fell on Monday, with the MSCI Asia ex Japan down more than 1%. Oil prices briefly hit a five-month high, while the focus remains on a potential military response from Iran. [MKTS/GLOB] "Worries over potential supply disruptions from Strait of Hormuz is driving the sentiment," said Vinit Bolinjkar, head of research at Ventura Securities. About a fifth of the world's total oil consumption passes through the strait, which lies between Oman and Iran. Higher crude oil prices are a negative for India, which depends heavily on imports for its energy requirements, as they could stoke inflation and widen the fiscal deficit. Still, UBS said it does not see a prolonged disruption to oil supplies. "We believe that near-term downside in stocks could represent an opportunity for investors who are underallocated to equities to build positions," the brokerage said. Meanwhile, IT stocks shed 1.8% after Accenture posted a third consecutive quarter of yearly decline in outsourcing orders as a cutback in U.S. government spending and tariff uncertainty pressured economic growth. Indian IT firms get a significant chunk of their revenue from the U.S. In contrast, small finance banks rose after the central bank reduced the mandated portion of lending to priority sectors to 60% from 75%. (Reporting by Vivek Kumar M; Editing by Sonia Cheema and Mrigank Dhaniwala)


Time of India
37 minutes ago
- Time of India
Ola Electric shares slide 6% to all-time low after fresh block deal
Shares of Ola Electric Mobility dropped 6% on Monday to an all-time low of Rs 43.20 on the BSE, after 0.8% of the company's equity changed hands in block deals. The identities of the buyers and sellers were not immediately known. Earlier this month, a block deal worth Rs 731 crore saw 14.22 crore shares—representing 3.23% equity—change hands at an average price of Rs 51.40. Hyundai Motor Company was the reported seller in that transaction. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Idols - Handmade Brass Statues for Home & Gifting Luxeartisanship Buy Now Undo Also Read: Why stock market is falling today? Key factors behind 900-point Sensex crash, Nifty below 24,850 Weak Q4 performance The stock's recent decline follows a weak March quarter earnings report. Ola Electric posted a net loss of Rs 870 crore in Q4 FY25, more than doubling from Rs 416 crore in the same quarter last year. Revenue from operations slumped 62% YoY to Rs 611 crore as vehicle deliveries fell to 51,375 units from 1.15 lakh a year ago. Live Events Also Read: Is the grey market premium misleading? Decoding the valuation gap in HDB Financial's IPO Auto EBITDA margin plunged to -78.6% from -9.3% in Q4 FY24, while consolidated EBITDA margin dropped to -101.4%, impacted by high provisioning and weak operating leverage. However, gross margin improved slightly to 19.2%, supported by better monetisation and a higher share of Gen-3 platform vehicles, which offer 20% more power and range at 11% lower cost than Gen-2 models. For FY25, the company delivered 3.59 lakh vehicles, up from 3.29 lakh in FY24. Full-year adjusted revenue stood at Rs 4,665 crore, with a consolidated EBITDA margin of -34.6%. Also Read: 11 Nifty mid & smallcap stocks that can rally 40-90% over the next 12 months Stock performance and price target Ola Electric's shares have fallen over 43% from their IPO price of Rs 76. The company debuted on August 9, 2024, listing at Rs 91.20 per share. The stock is now down 49% year-to-date and has fallen 72% from its 52-week high of Rs 157.50. According to Trendlyne, the average analyst target for Ola Electric is Rs 59, implying a potential upside of nearly 35%. Among the seven analysts tracking the stock, the consensus rating is 'Hold'. Ola Electric, known for its electric scooters, has faced criticism over customer service and repair issues, which have also attracted regulatory scrutiny. Despite ongoing expansion plans in the EV ecosystem, these challenges continue to weigh on investor sentiment. The company's current market capitalisation stands at Rs 19,407 crore. Also Read: $2.4 trillion worth of gold! India's household hoard is 6x Pakistan's economy ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)